May/June 2011 – Carpe Diem: Savings with Generics, and Drug Plans or Dealer Supply Chains

June 2011

IN THIS ISSUE...HIV treatment: earlier is better...NOC Watch: Abstral, Gelnique...FEATURES: Carpe Diem – Savings with Generics in 2011...Drug plans or dealer supply chains? View post


HIV treatment: earlier is better

June 2011

The results of a new major international study may lead to more patients being treated with HIV therapies earlier in the course of their disease.  At an average treatment cost of $15,000 CAD per individual per year, and with side-effects ranging from View post


NOC Watch – Abstral, Gelnique

June 2011

Abstral is a new sublingual formulation (i.e. dissolving under the tongue) of the potent narcotic pain reliever, fentanyl, a drug which is currently only available as a patch or by injection...Gelnique is a new formulation of an existing oral drug product, oxybutynin chloride, used to assist patients with overactive bladder. View post


Carpe Diem – Savings with Generics in 2011

June 2011

A new study at the University of British Columbia suggested that Canada could save almost $1.3 billion per year if all provinces followed the pricing model for generic drugs implemented by the publicly-funded Ontario Drug Benefit (ODB) Program... View post


Drug plans or dealer supply chains?

June 2011

While many people are aware of the abuse and misuse of prescription narcotic medications through various reports in news media, most do not realize or consider that employer-sponsored drug plans may be footing the bill for these practices.  In fact, the ease View post


Latest News